SHF | HCV INITIATIVE A Center of Excellence As a center of - PowerPoint PPT Presentation

SHF | HCV INITIATIVE

A Center of Excellence As a center of Excellence, St. Hope Foundation is nonprofit community healthcare organization that was established in November 1999. Recently, St. Hope implemented the Patient Centered Medical Home model of care. FQHC - As a comprehensive Federally Qualified Health Center St. Hope targets unmet needs and gaps in health- related services, fostering client-centered programs to meet these needs.

HCV Initiative St. Hope have medical experts fully competent in treating Hepatitis C. Under the clinical direction of Stanley Lewis, M.D., MPH, AAHIVS Dr. James Sims, III, M.D., AAHIVS • Internal medicine and infectious disease physicians The medical team stays abreast of the latest advancements in medical treatment. • With the new treatment developments for Hepatitis C and B, it has afforded patients more effective options to treat and clear or control these viruses.

What We Offer Hepatitis C or B Diagnosed Patients 1. Thoughtful and expert consultation during your initial visit 2. Evaluation to determine if treatment is appropriate 3. Assignment to a specialized Care Team for Hepatitis C and Hepatitis B Treatment 4. Case Manager assignment to help enroll patient in Patient Assistance Programs 5. Mental Health Counseling services 6. Annual Physical exam 7. Urgent Care: cold, fever, cuts, bruises, cough

Initial Workup Prior to Consideration for HCV Therapy Medical Hx & P.E. Body wt, vital signs (BP, HR, Temp) Ophthalmoscopic Exam All patients should receive an eye examination at baseline Clinical Chemistry ALT, AST, T.bilirubin, Alk phos, T. Protein, albumn, BUN, serum creatinine, uric acid, calcium, phosphorus, cholesterol, triglycerides, serum glucose, sodium, chloride and potassium Child-Pugh Score Treatment is contraindicated in HCV-monoinfected patients with Child-Pugh score >6 and in HCV/HIV coinfected patients with Child-Pugh score > 6 Psychological Assessment Assess history of depression Hematology Completed blood count (hematocrit, hemoglobin, WBC, platelets) including differential, prothrombin time, partial thromboplastin time Immunology Assess risk for autoimmune disease Alpha-fetoprotein In conjunction with other tests to screen for liver cancer Thyroid Function TSH, T4 Drug Screen In order to detect drugs of abuse, except for methadone Chest X-ray For patients with pre-existing pulmonary disease Electrocardiogram Patients >50 years of age, and anyone else with a history of pre-existing cardiac disease to assess cardiovascular risk Liver biopsy As appropriate HCG Pregnancy Test For women of childbearing potential before, during and 6 months after treatment HCV Genotype Helps determine treatment regimen and duration Quantitative HCV RNA Baseline level is important for comparison, especially at Wk 4 and Wk 12 of therapy Measurement

Outside Labs Accepted by our Providers Hepatitis Panel (A,B,C) No Time Limit (documentation is available) Hepatitis C Antibody No Time Limit (documentation is available) Hepatitis C Genotype No Time Limit (documentation is available) HIV Dx Documentation within 30 days of visit HCV Viral Load Documentation within 30 days of visit CMP & CBC Documentation within 30 days of visit PT/PTT, Alpha Fetal Documentation within 30 days of visit Protein, TSH Drug Screen (Medicaid Documentation within 60 days of visit Patients)

Questions?